Med BioGene - News Archives 2008

Featured News

February 17, 2010

Med BioGene Announces Results of Annual and Special Meeting

January 20, 2010

Med BioGene Announces Date of Annual and Special Meeting and Adoption of Shareholder Rights Plan

January 18, 2010

Med BioGene Appoints World-Renowned Genticist Dr. Michael R. Hayden as Director

December 29, 2009

Med BioGene Files Registration Statement for Proposed U.S. IPO

December 03, 2009

Med BioGene Announces Poster Presentations of LungExpress Dx™ Validation Study and Health Economics Evaluation at AACR – IASLC Meeting in January

October 15, 2009

Med BioGene Announces Positive Results from Validation Study of LungExpess Dx™

August 17, 2009

Med BioGene Reports Financial Results for the Second Quarter 2009

July 16, 2009

Med BioGene and the University of Ottawa Heart Institute Publish Study Demonstrating Potential New Diagnostic and Therapeutic Gene Expression Markers for Coronary Artery Disease

July 14, 2009

Med BioGene Increases Private Placement

June 25, 2009

Med BioGene Announces Closing of Second Tranche of Private Placement

June 05, 2009

Med BioGene Announces Closing of First Tranche of Private Placement

April 22, 2009

Med BioGene Announces Private Placement and Lead Order

March 18, 2009

Med BioGene Expands Collaboration with University Health Network for Novel Gene Markers Predictive of Chemotherapy Response in Lung Cancer

March 16, 2009

Med BioGene Appoints Life Science Veteran as Chief Financial Officer

News Archives

2008

News Archives 2008

November 28, 2008

Med BioGene Reports Financial Results for the Third Quarter 2008

October 23, 2008

Med BioGene Broadens Commercialization Team to Oversee Launch Preparations for LungExpress Dx™

September 18, 2008

Med BIoGene Completes Final Tranche of Financing

August 29, 2008

Med BioGene Reports Financial Results for the Second Quarter 2008

August 07, 2008

Med BioGene Completes First Tranche of Financing

July 07, 2008

Med BioGene Announces Financing

June 16, 2008

Med BioGene Expands Lymphoma Collaboration; Becomes Founding Corporate Collaborator of Translational Working Group in Hematologic Malignancies

May 30, 2008

Med BioGene Reports Financial Results for the First Quarter 2008

May 29, 2008

Med BioGene Appoints Diagnostics Industry Veteran Dr. Heiner Dreismann to Board of Directors

April 29, 2008

Med BioGene Presents Financial Results for 2007

April 23, 2008

Med BioGene and University Health Network Collaborate to Commercialize Critical Lung Cancer Prognostic Test

April 03, 2008

Med BioGene Confirms High Accuracy Rate for LymphExpress Dx™

February 19, 2008

Med BioGene Appoints Diagnostics Industry Veteran Dennis L. Grimaud to Board of Directors

E-MAIL ALERTS

Subscribe to our e-mail news alerts